2001
DOI: 10.1139/o00-090
|View full text |Cite
|
Sign up to set email alerts
|

Human growth factor receptor bound 14 binds the activated insulin receptor and alters the insulin-stimulated tyrosine phosphorylation levels of multiple proteins

Abstract: To identify proteins interacting in the insulin-signaling pathway that might define new pathways or regulate existing ones, we have employed the yeast two-hybrid system. In a two-hybrid screen of a human liver cDNA library, we identified the human growth factor receptor bound 14 (hGrb14) adaptor protein as a partner of the activated insulin receptor. Additional analysis of the insulin receptor--hGrb14 interaction in the yeast two-hybrid system revealed that the SH2 domain of hGrb14 was not the sole region invo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
22
0

Year Published

2002
2002
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(25 citation statements)
references
References 34 publications
2
22
0
Order By: Relevance
“…Grb14 binds activated IR (30) and inhibits the phosphorylation of IR substrates (6). Overexpression of Grb14 has been shown to inhibit the activation of downstream insulin signaling cascades (6,26,30). Consistent with the role of Grb14 as an inhibitor of IR signaling, Grb14 Ϫ/Ϫ mice display improved glucose tolerance, increased insulin sensitivity, and enhanced insulin signaling (14).…”
Section: Discussionmentioning
confidence: 78%
“…Grb14 binds activated IR (30) and inhibits the phosphorylation of IR substrates (6). Overexpression of Grb14 has been shown to inhibit the activation of downstream insulin signaling cascades (6,26,30). Consistent with the role of Grb14 as an inhibitor of IR signaling, Grb14 Ϫ/Ϫ mice display improved glucose tolerance, increased insulin sensitivity, and enhanced insulin signaling (14).…”
Section: Discussionmentioning
confidence: 78%
“…Grb14 is selectively expressed in insulin-sensitive tissues and upon insulin stimulation interacts in vivo with the insulin receptor (IR). Moreover, the overexpression of Grb14 in the CHO-IR cell line was shown to inhibit insulin-stimulated tyrosine phosphorylation of specific proteins, like IRS-1, and distal effects, like DNA and glycogen synthesis (23,28). Despite controversial findings (46,52,71), overexpression studies of Grb10 isoforms are also consistent with a negative role in insulin signaling (34,44,48).…”
mentioning
confidence: 95%
“…Overexpression of Grb14 in CHO-IR cells inhibits insulinstimulated DNA and glycogen synthesis or tyrosine phosphorylation of proteins [8,9]. In vitro tyrosine kinase assays have shown that the Grb7 family members inhibit the IR catalytic activity, and that Grb14 is the most potent inhibitor [10,11].…”
Section: Introductionmentioning
confidence: 99%